Search Results | DrugBank Online

Displaying drugs 9301 - 9325 of 9337 in total

7-thionicotinamide-adenine-dinucleotide phosphate

Experimental

Thionicotinamide-Adenine-Dinucleotide

Experimental

Niguldipine

Niguldipine is a calcium channel blocker drug (CCB) with a1-adrenergic antagonist properties.

Experimental

PCO-371

PCO-371 is under investigation in clinical trial NCT02475616 (A Single Ascending Dose Study of PCO371 in Healthy Volunteers).

Investigational

N-naphthalen-1-ylmethyl-2'-[3,5-dimethoxybenzamido]-2'-deoxy-adenosine

Experimental

N(4)-Adenosyl-N(4)-methyl-2,4-diaminobutanoic acid

N(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid is a solid. This compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar.

Experimental

2'-O-Acetyl Adenosine-5-Diphosphoribose

Experimental

N-[1,3-Di(4-morpholinyl)-2-propanyl]-3-(α-D-galactopyranosyloxy)-5-nitrobenzamide

Experimental

(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine

Experimental

Benidipine has the formula 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 1-(phenylmethyl)-3-piperidinyl ester hydrochloride. It is a synthetic dihydropyridine derivative that has anti-hypertensive and anti-anginal actions. It was originated in Japan by Kyowa Hakko, it is submitted for FDA approval and it is currently available in some Asian countries like India and Japan.[L1385, L1386]

Experimental